Clinical trial
Vanguard Study for Head and Neck Cancer or Non-Small Cell Lung Cancer (NSCLC)…
NCT00352391 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00352391 |
|---|---|
| Title | Vanguard Study for Head and Neck Cancer or Non-Small Cell Lung Cancer (NSCLC) Patients |
| Official title | Vanguard Study Characterizing Occurrence of Recurrent or Second Primary Tumors in Patients With Prior History of Definitively Treated Stage I/II Head and Neck or Non-Small Cell Lung Cancer Who Are Current or Former Smokers |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | United States Department of Defense U.S. Fed |
| Status | Completed |
| Study type | Observational |
| Conditions | Head and Neck Cancer, Lung Cancer |
| Intervention type | Other |
| Interventions | Assessments |
| Enrollment | 54 |
| Start date | Aug 1, 2004 |
| Primary completion | Jan 1, 2016 |
| Completion | Jan 1, 2016 |
| First posted | Jul 14, 2006 |
| Last update posted | Feb 3, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: